K
Kirstine Stochholm
Researcher at Aarhus University Hospital
Publications - 79
Citations - 4053
Kirstine Stochholm is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Population & Turner syndrome. The author has an hindex of 27, co-authored 71 publications receiving 3082 citations. Previous affiliations of Kirstine Stochholm include Odense University Hospital & Charité.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus Højbjerg Gravholt,Niels Holmark Andersen,Gerard S. Conway,Olaf M. Dekkers,Mitchell E. Geffner,Karen O Klein,Angela E. Lin,Nelly Mauras,Charmian A. Quigley,Karen Rubin,David E. Sandberg,Theo C. J. Sas,Michael Silberbach,Viveca Söderström-Anttila,Kirstine Stochholm,Janielle A van Alfen-van derVelden,Joachim Woelfle,Philippe Backeljauw +17 more
TL;DR: An international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016, the present guidelines related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy.
Journal ArticleDOI
Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome
TL;DR: Patients with TS and especially the karyotypes 45,X and isoXq have a higher mortality compared with the background population, and there was a steady increase in prevalence, but incidence was unchanged.
Journal ArticleDOI
Clinical and epidemiological description of aortic dissection in Turner's syndrome
Claus Højbjerg Gravholt,Kerstin Landin-Wilhelmsen,Kirstine Stochholm,Britta E Hjerrild,Thomas Ledet,C. B. Djurhuus,Lisskulla Sylvén,Ulrik Baandrup,Bent Østergaard Kristensen,Jens Sandahl Christiansen +9 more
TL;DR: Aortic dissection is extremely common in the setting of Turner's syndrome, and occurs early in life, and patients with Turner's Syndrome should be offered a protocol for clinical follow-up similar to that provided for patients with Marfan syndrome.
Journal ArticleDOI
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults
David B. Allen,Philippe Backeljauw,Martin Bidlingmaier,Beverly M. K. Biller,Margaret C. S. Boguszewski,Pia Burman,Gary Butler,Kazuo Chihara,Jens Sandahl Christiansen,Stefano Cianfarani,Peter E. Clayton,David R. Clemmons,Pinchas Cohen,Feyza Darendeliler,Cheri Deal,David B. Dunger,Eva Marie Erfurth,John S. Fuqua,Adda Grimberg,Morey W. Haymond,Claire E Higham,Ken K. Y. Ho,Andrew R. Hoffman,Anita C. S. Hokken-Koelega,Gudmundur Johannsson,Anders Juul,John J. Kopchick,Peter A. Lee,Martin R. Pollak,Sally Radovick,Leslie L. Robison,Ron Rosenfeld,Richard J. Ross,Lars Sävendahl,Paul Saenger,H. Toft Sorensen,Kirstine Stochholm,Christian J. Strasburger,Anthony J. Swerdlow,Michael O. Thorner +39 more
TL;DR: For instance, the European Society of Paediatric Endocrinology (ESPE), the GRS, and the Pediatric Endocrine Society (PES) convened a meeting to re-raise the safety of recombinant human GH (rhGH) as discussed by the authors.
Journal ArticleDOI
Turner syndrome: mechanisms and management.
TL;DR: An updated Review of Turner syndrome is presented, covering advances in genetic and genomic mechanisms of disease, associated disorders and multidisciplinary approaches to patient management, including growth hormone therapy and hormone replacement therapy.